On the basis of these results, the researchers propose a molecular stratification of glioblastoma consisting of four clinically relevant tumor subtypes—classical, mesenchymal, proneural and neural.
AbbVie is the latest company to have an investigational drug for glioblastoma multiforme (GBM ... This is the second phase 3 trial of the drug to end in failure. At an ASCO meeting in 2017 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback